International law firm Hill Dickinson has acted for pharmaceutical manufacturer NuPharm Group and its wholly-owned trading subsidiary NuPharm Laboratories, as it is acquired by Quantum Pharma in a £13m deal.

Hill Dickinson’s corporate team, led by Ian Riggs with assistance from Mercy Mba and James Down, advised the sellers on the deal.

Deeside-based NuPharm, founded in 2000, is an outsourced manufacturer for solid and liquid dose small batch-made specials and niche licensed pharmaceutical products. It operates from facilities in North Wales, and generated revenues of £3.85m and adjusted EBITDA of £1.09m in the year to 31 December 2014.

Quantum Pharma, based in Durham, is a growing pharmaceutical manufacturer supplying the health and care sectors. 

The deal sees Quantum Pharma acquire 100% of the share capital of NuPharm and its trading subsidiary NuPharm Laboratories for £9.34m paid in cash on completion and a maximum of £4m potentially payable under earn-out arrangements.